A Study of Ascending Single Doses of Surotomycin in Healthy Participants (MK-4261-008)

Clinical trial NCT02835105 · COMPLETED

Trial details

NCT number: NCT02835105
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Clostridium Difficile Associated Diarrhea (CDAD)

Start date: 2009-01-01
Primary completion: 2009-03-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.